I interviewed Dr. Sumanta Pal, co-director of the Kidney Cancer Program, City of Hope, about a study he led on the effects of continuing immunotherapy in metastatic kidney cancer patients after it has stopped working.
Episode Sponsored By https://www.carta.healthcare/
Episode Resources
- Connect with Arundhati Parmar
- [email protected]
- https://twitter.com/aparmarbb?lang=en
- https://medcitynews.com/
- Connect with Dr. Sumanta Pal
- https://www.cityofhope.org/sumanta-pal
Review, Subscribe and Share If you like what you hear please leave a review by clicking here
Make sure you're subscribed to the podcast so you get the latest episodes.
- Click here to subscribe with Apple Podcasts
- Click here to subscribe with Spotify
- Click here to subscribe with Podbean
- Click here to subscribe with RSS